The term “cachexia” is derived from the Greek words kakos (bad) and hexis (habit).
Cachexia is a malnutrition associated with chronic diseases such as cancer, chronic heart …

Cancer cachexia has long been perceived as a nutritional syndrome. However, nutritional
interventions have continued to be ineffective. With the recent recognition of the importance …

Cancer cachexia is a multifactorial syndrome characterized by a progressive loss of skeletal
muscle mass, along with adipose tissue wasting, systemic inflammation and other metabolic …

Life expectancy is increasing and so is the prevalence of age-related non-communicable
diseases (NCDs). Consequently, older people and patients present with multi-morbidities …

It has frequently been shown that patients with cancer are one of the largest hospital patient
groups with a prevalence for malnutrition. Weight loss is a frequent manifestation of …

In cancer cachexia trials, measures of physical function are commonly used as endpoints.
For drug trials to obtain regulatory approval, efficacy in physical function endpoints may be …

There is growing interest from the oncology community to understand how body composition
measures can be used to improve the delivery of clinical care for the 18.1 million individuals …

Malnutrition, muscle loss, and cachexia are prevalent in cancer and remain key challenges
in oncology today. These conditions are frequently underrecognized and undertreated and …

Background Sarcopenia, defined as decreased skeletal muscle mass, is prevalent and
associated with poor prognosis in various solid tumors. This study aimed to determine the …

Background Cachexia is a multisystem syndrome characterized by weight loss, anorexia,
loss of muscle mass, systemic inflammation, insulin resistance, and functional decline …